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Abstract	  The	  pathological	  formation	  of	  proteinaceous	  aggregates	  that	  accumulate	  into	  the	  brain	   cells	   of	   patients	   are	   hallmarks	   of	   neurodegenerative	   diseases	   such	   as	  Alzheimer’s	  disease,	  amyotrophic	  lateral	  sclerosis	  and	  the	  heterogeneous	  group	  of	  polyglutamine	  (polyQ)	  diseases.	  In	   the	  polyQ	  diseases,	   the	  most	  upstream	  events	  of	   the	  pathogenic	  cascade	  are	  the	  misfolding	   and	   aggregation	   of	   proteins,	   such	   as	   huntingtin	   in	  Huntington’s	  disease,	   that	   contain	   expanded	   stretch	   of	   glutamine	   residues	   above	   35-­‐40	  repeats.	  This	  expanded	  polyQ	  stretch	  triggers	  the	  misfolding	  and	  aggregation	  of	  cytotoxic	  polyQ	  proteins	   in	   the	  neurons	   that	   cause	  cell	  death	   through	  different	  processes,	   like	   apoptosis,	   excessive	   inflammation,	   formation	   of	   free	   radicals,	  eventually	  leading	  to	  neuronal	  loss	  and	  neurodegeneration.	  This	   study	   focuses	   on	   the	   cellular	   network	   of	   chaperone	   proteins	   that	   can	  prevent	  protein	  aggregation	  by	  binding	  misfolding	  intermediates	  and	  may,	  as	  in	  the	   case	  of	  HSP70,	   actively	  unfold	  misfolded	  proteins	   into	   refoldable	  non-­‐toxic	  ones	   (Hinault	   et	   al.,	   2010;	   Sharma	   et	   al.,	   2011).	   The	   chaperones	   can	   also	  collaborate	   with	   the	   proteasome	   to	   convert	   stable	   harmful	   proteins	   into	  harmless	  amino	  acids.	  Thus,	  the	  chaperone	  proteins	  that	  are	  the	  most	  important	  cellular	   factors	   of	   prevention	   and	   curing	   of	   protein	   misfolding,	   are	   negatively	  affected	  by	  aging	  (Morley	  et	  al.,	  2002)	  and	  fail	  to	  act	  properly	  in	  the	  neurons	  of	  aged	  persons,	  which	  eventually	  may	  lead	  to	  neurodegenerative	  pathologies.	  The	   general	   aim	   of	   this	   research	   was	   to	   identify	   least	   toxic	   drugs	   that	   can	  upregulate	   the	   expression	   of	   chaperone	   genes	   in	   cells	   suffering	   from	   polyQ-­‐mediated	  protein	  aggregation	  and	  degeneration.	  The	   specific	   aim	  of	   this	   study	  was	   to	   observe	   the	   effect	   of	   ten	   drugs	   on	   polyQ	  aggregation	   in	   a	   recombinant	   nematode	   Caenorhabditis	   elegans	   expressing	   a	  chimeric	   protein	   containing	   a	   sequence	   of	   35	   glutamines	   (Q35)	   fused	   to	   the	  green	  fluorescent	  protein	  in	  muscle	  cells,	  which	  causes	  an	  age-­‐	  and	  temperature-­‐dependent	   phenotype	   of	   accelerated	   paralysis.	   The	   drugs	   were	   selected	   after	  having	   proven	   their	   causing	   the	   overexpression	   of	   chaperone	   proteins	   in	   a	  previous	  wide	  screening	  of	  2000	  drugs	  on	  the	  moss	  plant	  Physcomitrella	  patens.	  The	   screening	   that	   we	   performed	   in	   this	   study	   was	   on	   these	   ten	   drugs.	   It	  suggested	  that	  piroxicam	  and	  anisindione	  were	  good	  reducers	  of	  polyglutamine	  disease	  mediated	  paralysis.	  A	  hypothesis	  can	  be	  made	  that	  they	  may	  act	  as	  good	  enhancers	  of	  the	  heat	  shock	  response,	  which	  causes	  the	  overexpression	  of	  many	  HSP	   chaperones	   and	   thus	   reduce	   motility	   impairment	   of	   polyQ	   disease	  expressing	   nematodes.	   Piroxicam	   was	   found	   to	   have	   the	   greatest	   effect	   on	  reducing	   polyQ35	  proteins	   aggregates	  mediated	   paralysis	   in	   a	   dose-­‐dependent	  manner	  but	  was	  also	   found	   to	  either	  have	  a	   toxic	  effect	  on	  wild	   type	  C.elegans,	  either	  to	  change	  its	  natural	  motility	  behavior,	  eventually	  reducing	  its	  motility	  in	  both	   cases.	   Chloroform	   should	  be	  preferred	  over	  DMSO	  as	   a	  drug	   solvent	   as	   it	  appears	  to	  be	  less	  toxic	  to	  C.elegans.	  
Keywords	  :	   	  Caenorhabditis	  elegans,	  polyglutamine,	  piroxicam,	  anisindione,	  heat	  shock	  proteins.	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Introduction	  Neurodegenerative	   diseases	   are	   a	   group	   of	   pathologies	   of	   great	   importance.	  Alzheimer’s	  disease,	  amytrophic	  lateral	  sclerosis,	  the	  polyglutamine	  diseases	  and	  Parkinson’s	  disease	  are	  just	  a	  few	  examples	  of	  this	  huge	  group	  of	  diseases	  known	  as	  the	  neurodegenerative	  diseases.	  Their	  frequency	  and	  their	  severity	  rendered	  them	  an	  important	  medical	  challenge	  worth	  studying.	  Neurodegenerative	   diseases	   result	   from	   progressive	   neuronal	   loss,	   leading	   to	  dysfunction	  of	  the	  nervous	  system.	  According	  to	  the	  American	  National	  Institute	  of	   Neurological	   Disorders	   and	   Stroke,	   there	   are	   more	   than	   600	   neurologic	  disorders	   resulting	   from	  degenerative	  neuronal	   loss,	   affecting	  about	  50	  million	  of	  Americans	  each	  year	  (Brown	  et	  al.,	  2005).	  Because	  of	  the	  importance	  of	  the	  number	  of	  different	  pathologies	  considered	  as	  neurodegenerative	   disease,	   it’s	   difficult	   to	   find	   worldwide	   statistics	   about	   the	  whole	   group.	   An	   indirect	   way	   to	   measure	   the	   importance	   of	   its	   general	  epidemiology	   is	   to	   focus	   on	   dementia,	   which	   is	   a	   main	   outcome	   of	   numerous	  neurodegenerative	   diseases.	   According	   to	   the	   DSM-­‐IV,	   a	   diagnosis	   of	   the	  syndrome	   of	   dementia	   recquires	   a	   mnesic	   disorder,	   along	   with	   one	   of	   the	  following	   features:	   aphasia,	   apraxia,	   agnosia	   and	   executive	   functions	   disorder.	  Cognitive	  troubles	  with	  negativ	  impact	  on	  everyday	  life	  should	  also	  be	  part	  of	  the	  symptoms	  to	  establish	  the	  diagnosis	  of	  dementia	  (Monsch	  et	  al.,	  2008).	  Worldwide	   about	   35.6	   million	   people	   were	   living	   with	   dementia	   in	   2010.	  Estimations	   are	   that	   this	   number	   will	   reach	   65.7	   million	   by	   2030	   and	   115.4	  million	  by	  2050	  (Wimo	  et	  al.,	  2010).	  	  In	  Switzerland,	  about	  98’000	  persons	  were	  affected	  in	  2008	  and	  23'000	  persons	  are	  developing	  this	  syndrome	  each	  year	  (Monsch	  et	  al.,	  2008).	  The	  annual	  cost	  of	  dementia	   was	   estimated	   worldwide	   at	   US$	   604	   billions	   in	   2010	   (Wimo	   et	   al.,	  2010)	  and	  at	  CHF	  6.3	  billions	  for	  2007	  in	  Switzerland	  (Ecoplan,	  2010).	  As	   defects	   in	   the	   genome	   are	   essentials	   for	   the	   pathogenesis	   of	   these	  neurodegenerative	  diseases,	  their	  hereditary	  character	  has	  also	  to	  be	  taken	  into	  account	  to	  measure	  the	  importance	  of	  this	  group	  of	  disease.	  Neurodegenerative	  diseases	  may	  cause	  as	  well	  many	  different	  symptoms	  other	  than	  dementia,	  sometimes	  in	  addition	  to	  it,	  sometimes	  without	  it.	  	  For	  example	  amyotrophic	  lateral	  sclerosis,	  which	  causes	  the	  progressive	  loss	  of	  the	  motor	  neurons,	  will	  cause	  physical	  symptoms	  such	  as	  dysphagia,	  dysphonia,	  loss	  of	  muscular	   strength,	   amyotrophy	  and	   cramps.	  Parkinson’s	  disease	   causes	  mostly	   movement-­‐related	   symptoms,	   like	   rigidity,	   slowness	   in	   making	  movement	   and	   shaking	   among	   others.	   Other	   neurodegenerative	   diseases	   may	  cause	  other	  symptoms	  (Bertram	  et	  al.,	  2005).	  The	  medical	  world	  still	  offers	  limited	  treatments	  to	  many	  of	  these	  diseases	  and	  most	   of	   the	   time	   only	   symptomatic	   treatment	   can	   be	   offered,	   without	   really	  restraining	  the	  development	  of	  the	  disease.	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Affected	  brain	  regions	  
Huntington’s	  
Disease	  
Huntingtin	   6-­‐35	   38-­‐180	   Cytoplasmic	   Striatum,	  cortex	  
DRPLA	   Atrophin-­‐1	   6-­‐35	   49-­‐88	   Nuclear	   and	  cytoplasmic	   Cerebral	  cortex	  
SBMA	   Androgen	  receptor	   9-­‐36	   38-­‐65	   Nuclear	   and	  cytoplasmic	   Motor	  neurons	  
SCA	  1	   Ataxin-­‐1	   6-­‐44*	   39-­‐82	   Nuclear	   and	  cytoplasmic	   Cerebellum	  
SCA	  2	   Ataxin-­‐2	   15-­‐31	   34-­‐64	   Cytoplasmic	   Cerebellar	  Purkinje	  cells	  
SCA	  3/MJD	   Ataxin-­‐3	   12-­‐40	   60-­‐84	   Nuclear	   and	  cytoplasmic	   Ventral	   pons,	   substantia	  nigra	  
SCA	  6	   Calcium	  channel	   4-­‐18	   21-­‐33	   Membrane	  associated	   Cerebellar	  Purkinje	  cells	  
SCA	  7	   Ataxin-­‐7	   4-­‐35	   34-­‐306	   Nuclear	   and	  cytoplasmic	   Cerebellar	   Purkinje	   cells,	  brain	  stem,	  spinal	  cord	  
SCA	  17	   Tata-­‐binding	  protein	  (TBP)	   29-­‐42	   47-­‐55	   Nuclear	   Cerebellar	  Purkinje	  cells	  
Table	  1:	  Overview	   of	   the	   polyQ	   pathologies.	  DRPLA:	  Dentatorubral-­‐pallidoluysian	  atrophy;	  SBMA:	  spinobulbar	  muscular	  atrophy;	  SCA:	   spinocerebellar	  ataxia;	  MJD:	  Machado-­‐Joseph	  disease.	   (Paulson	  et	  al.,	  2000;	   Nagai	   et	   al.,	   2010)	   *In	   SCA1,	   disease	   alleles	   are	   purely	   CAG	   repeats,	   whereas	   normal	   alleles	   >	   21	  repeats	  are	  interrupted	  by	  1-­‐3	  CAT	  units.	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Chaperone	  proteins:	  In	   this	   study	   we	   focused	   on	   the	   polyQ	   diseases,	   but	   most	   of	   the	  neurodegenerative	   diseases	   have	   something	   in	   common:	   Degeneration	   and	  neuronal	  loss	  caused	  by	  the	  toxic	  aggregation	  of	  misfolded	  proteins	  into	  the	  cells.	  Hence	  finding	  a	  way	  of	  avoiding	  the	  aggregation	  of	  proteins	  would	  probably	  slow	  down	  or	  even	  stop	  the	  progress	  of	  such	  diseases.	  This	   leads	   us	   to	   the	   concept	   of	   the	   molecular	   chaperones.	   The	   molecular	  chaperones	  are	  a	  group	  of	  proteins	  that	  can	  prevent	  the	  aggregation	  of	  proteins,	  and	  some	  of	  them	  can	  also	  unfold	  misfolded	  proteins	  and	  thus	  reduce	  a	  possible	  damaging	  effect	  by	  misfolded	  proteins	  in	  the	  cell.	  They	  can	  be	  define	  as	  proteins	  that	   interact,	   stabilize,	   or	   help	   a	   non-­‐native	   protein	   to	   acquire	   its	   native	  conformation,	  but	  that	  are	  not	  present	  in	  the	  final	  functional	  structure	  (Hartl	  and	  Hayer-­‐Hartl	  et	  al.,	  2009). Most	   molecular	   chaperones	   can	   passively	   prevent	   the	   toxic	   aggregation	   by	  binding	   the	   misfolded	   proteins	   and	   preventing	   them	   to	   form	   an	   aggregate.	  Others	   can	   hydrolyze	   ATP	   to	   convert	   stable	   toxic	   protein	   aggregates	   into	  harmless	  natively	  refoldable	  polypeptides.	  During	  de	  novo	  protein	  synthesis,	  or	  protein	  translocation	  into	  the	  mitochondria,	  polypeptides	   are	   unfolded	   when	   they	   emerge	   from	   the	   ribosome	   or	   the	  translocation	   pores.	   When	   their	   hydrophobic	   parts	   are	   in	   contact	   with	   water,	  they	   tend	   to	   spontaneously	   collapse	   so	   that	   these	  parts	  will	   be	   the	   core	   of	   the	  proteins,	  surrounded	  by	  the	  hydrophilic	  parts	  (Morgan	  et	  al.,	  1998).	  This	   is	  the	  folding	  of	  the	  proteins	  into	  the	  «	  native	  state	  »,	  which	  is	  thermodynamically	  more	  stable	  than	  the	  unfolded	  state	  In	  a	  cell	  we	  can	  also	  find	  some	  folded	  proteins	  in	  a	  so	  called	  «	  alternative-­‐state	  »,	  for	   example	  when	   a	   protein	   is	   in	   an	   inactive	   albeit	  misfolded	   state,	   awaiting	   a	  phosphorylation	   to	   become	   active	   in	   the	   cell.	   That	   would	   be	   a	   physiologic	  harmless	  oligomer	   in	  opposition	   to	   the	   folded	  monomer	   in	  a	  «	  native	  state	  ».	   It	  would	  cost	  too	  much	  energy	  to	  degrade	  all	  the	  proteins	  that	  are	  misfolded	  or	  in	  «	  alter-­‐native	  state	  »	   and	   create	   again	   natively	   folded,	   functional	   and	   harmless	  proteins,	  so	  the	  cells	  had	  to	  find	  a	  way	  to	  spot	  precisely	  the	  misfolded	  proteins	  and	   convert	   them	   into	   the	   desired	   proteins	   (Hinault	   et	   al.,	   2006).	   This	   is	   the	  function	   of	   the	  molecular	   chaperones.	   They	   are	   of	   great	   importance	   since	   the	  regulation	  of	  this	  tight	  equilibrium	  between	  functional	  natively	  folded	  and	  non-­‐functional	  toxic	  misfolded	  proteins	  is	  vital	  to	  the	  cell.	  Two	  molecular	  chaperones	  in	   particular	   have	   been	   held	   responsible	   of	   this	   essential	   fold-­‐controlling	   task,	  HSP90	   and	   HSP70.	   HSP	   stands	   for	   «	  heat	   shock	   proteins	  »,	   the	   number	   is	   the	  apparent	  molecular	  weight	  in	  SDS-­‐polyacrylamid	  gels.	  	  There	   are	  many	   different	   families	   of	   chaperone	   proteins.	   The	   principal	   groups	  are	  described	  in	  table	  2.	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HSP70s	   and	   co-­‐
chaperones	   (such	   as	  
HSP40	  and	  HSP110)	  
In	  all	  ATP-­‐containing	  compartments	  of	  living	  organisms.	  Work	  with	  other	  proteins	  in	  the	  folding	  of	  nascent	  polypeptides,	  remodeling	  of	  native	   protein	   complexes,	   transduction	   of	   cellular	   signals,	  regulation	   of	   the	   cell	   cycle,	   proliferation,	   apoptosis,	   regulation	   of	  heat-­‐shock	  response	  (Jolly	  and	  Morimoto,	  2000)	  
HSP60	  and	  HSP10	   Control	  the	  proper	  folding	  of	  10-­‐15%	  of	  newly	  synthesized	  proteins	  in	  bacteria	  (Liberek	  et	  al.,	  2008)	  
HSP90	   family	   and	   co-­‐
chaperones	  
Mechanism	  still	  unclear,	  in	  vitro	  can	  prevent	  protein	  aggregation	  in	  an	   ATP-­‐independent	  manner	   (Wiech	   et	   al.,	   1992).	   They	   can	   form	  super	  complexes	  with	  HSP70	  to	  modify	   the	  structure	  of	  misfolded	  proteins	   bound	   to	   its	   docking	   site	   (Whitesell	   and	   Linquist,	   2005;	  Zhao	  et	  al.,	  2005)	  
Small	  HSPs	   They	   have	   a	   conserved	   α-­‐crystalline	   domain	   that	   passively	   binds	  misfolded	  intermediates	  and	  prevent	  misfolding	  polypeptides	  from	  aggregating,	  protect	  membrane	   from	  heat	  disruption	   (Jakob	  et	   al.,	  2003)	  
HSP100	   ATPase	  members	  of	  the	  AAA+	  superfamily,	  plays	  a	  vital	  role	  in	  the	  survival	   of	   bacteria,	   yeast,	   and	   plant	   cells	   exposed	   to	   chemical	  stresses	  or	  high	  temperatures	  (Sanchez	  and	  Lindquist,	  1990).	  
Table	  2:	  Major	  families	  of	  molecular	  chaperones.	  (Content	  from	  Finka	  et	  al.,	  2010)	  	  HSP70	   is	  a	  well	  known	  and	  highly	  conserved	  molecular	  chaperone	  protein	  and	  have	   multiple	   different	   functions	   in	   the	   protein	   homeostasis	   (see	   table	   2).	  Through	   the	   J-­‐domain	   of	   HSP70,	   the	   HSP40	   family	   of	   co-­‐chaperones	   can	   bind	  themselves,	   stimulating	   ATPase	   and	   folding	   activity.	   The	   other	   main	   groups	  structure	  and	  functions	  are	  described	  briefly	  in	  table	  2.	  Chaperone	   proteins	   are	   acting	   in	   physiological	   conditions	   already,	   to	   preserve	  the	   previously	   mentioned	   equilibrium,	   the	   proteostasis,	   but	   under	   certain	  conditions	   they	   can	   become	   greatly	   over	   expressed.	   Indeed	   many	   of	   the	  molecular	   chaperones	   are	   also	   stress-­‐induced.	   They	   may	   thus	   prevent	   the	  aggregation	  of	  the	  abnormally	  elevated	  number	  of	  misfolded	  proteins	  in	  stressful	  conditions.	   A	   well-­‐known	   stressfull	   condition	   is	   heat,	   hence	   their	   name,	   heat-­‐shock	  proteins	  (HSPs)	  (Finka	  et	  al.,	  2010).	  It	   should	  however	  be	  noted	  that	  most	  heat-­‐shock	  proteins	   are	  not	   chaperones,	  and	  that	  most	  chaperones	  are	  not	  heat-­‐induced.	  It’s	  an	  important	  notion	  to	  grasp	  correctly,	  as	  the	  concepts	  of	  HSPs	  and	  chaperones	  are	  tightly	  connected	  although	  they	  belong	  to	  several	  distinct	  protein	  families.	  Indeed	  although	  less	  than	  a	  third	  of	  the	  human	  chaperone	  genes	  are	  heat-­‐inducible,	  statistically	  a	  chaperone	  gene	  remains	   about	  10	   times	  more	   likely	   to	  be	  heat-­‐inducible	   that	   a	  non	   chaperone	  gene	  in	  the	  human	  genome	  (Finka	  et	  al.,	  2010).	  This	   stress	   response	   of	   the	   cell,	   inducing	   the	   activation	   of	   the	   heat	   shock	  proteins,	   many	   of	   which	   are	   chaperones,	   has	   been	   verified	   and	   used	   in	   many	  different	  experiences	  already.	  Saidi	  et	  al.	  made	  an	  interesting	  application	  of	  this	  stress	  response	  in	  2007.	  The	  purpose	  of	  their	  study	  was	  to	  measure	  the	  toxicity	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of	   organic	   pollutants	   on	   transgenic	   Physcomitrella	   patens	   by	   measuring	   the	  quantity	   of	   β-­‐glucuronidase	   (GUS),	   produced	   by	   the	   activity	   of	   GmHSP17.3B	  promoter	   that	   reacted	   to	   the	   stress	   induced	   by	   the	   pollutants.	   Chlorophenols,	  heavy	   metals	   and	   sulphonated	   anthraquinones	   specifically	   activated	   soybean	  heat	  shock	  GmHSP17.3B	  promoter,	  showing	  a	  correlation	  with	  long-­‐term	  toxicity.	  This	  method	  proved	  itself	  as	  a	  powerful	  method	  to	  observe	  the	  response	  of	  heat	  shock	  proteins	  in	  plants	  exposed	  to	  environmental	  or	  chemical	  stress.	  	  In	  2005,	  Saidi	  et	  al.,	  had	  already	  used	  the	  same	  promoter	  GmHSP17.3B	  as	  a	  tool	  to	   address	  whether	   if	   it	   was	   possible	   to	   produce	   a	   controlled	   production	   of	   a	  recombinant	   protein	   encoded	   after	   the	   GmHSP17.3B	   promoter.	   They	   used	   the	  transitory	   elevation	   of	   temperature,	   the	   so	   called	   «	  heat	   shock	  »,	   to	   trigger	   the	  stress	  response	  of	   the	  cells.	   Induction	   levels	  of	  protein	  production,	  which	  were	  tightly	  proportional	  to	  the	  temperature	  and	  duration	  of	  the	  heat	  shock	  treatment	  reached	  up	  to	  3000	  fold	  of	  increased	  cellular	  levels	  of	  reporter	  protein	  (Sidi	  et	  al.,	  2005)	  Chaperone	  proteins	  can	  also	  have	  other	  functions	  than	  proteostasis	  regulation	  in	  the	   cell	   and	   some	   of	   them	   can	   be	   found	   associated	   to	   the	   plasma	  membrane.	  Chaperone	   protein	   J3	   (DnaJ	   homolog	   3;	   HSP40-­‐like)	   in	   the	   case	   of	  Arabidopsis	  can	   influence	   the	   activity	   of	   H+-­‐ATPase	   that	   plays	   an	   essential	   role	   in	   many	  different	   vital	   processes	   of	   the	   cell.	   J3	   activates	   plasma	  membrane	   H+-­‐ATPase	  activity	  by	  physical	  interaction	  and	  by	  repressing	  PKS5,	  an	  inhibitor	  kinase	  of	  H+-­‐ATPase	  activity	  (Yang	  et	  al.,	  2010).	  	  
	  
Proteasome:	  Molecular	  chaperones	  are	  not	  working	  alone	  to	  regulate	  the	  protein	  homeostasis	  of	   the	   cell.	   Indeed	   the	   mechanism	   by	   which	   the	   cell	   is	   protected	   from	   the	  misfolded	   proteins	   damages	   is	   completed	   by	   the	   proteasome	   activity.	   The	  proteasome	   is	   an	   ATP-­‐dependent	   protease	   that	   cannot	   unfold	   misfolded	  proteins,	   unlike	   the	   chaperone	   proteins,	   but	   can	   degrade	   undesired	   proteins	  avoiding	   their	   accumulation	   in	   the	   cytosol.	   The	   proteasome	   constitutes	   nearly	  1%	  of	  all	  cellular	  proteins.	  About	  one	  third	  of	  the	  newly	  made	  polypeptide	  chains	  are	  degraded	  directly	   after	   their	   synthesis.	   The	  proteasome	  has	   a	   cylinder-­‐like	  structure,	   constituted	   of	   a	   central	   part,	   the	   20S	   core,	   itself	   formed	   by	  multiple	  proteins	  assembled	  in	  two	  heptameric	  rings	  stacked	  tail	  to	  tail.	  Each	  end	  of	  the	  20S	  core	  particle	  is	  associated	  with	  a	  bigger	  protein	  complex,	  the	  19S	  cap,	  acting	  as	  a	  gate	  for	  the	  proteasome.	  The	  19S	  caps	  can	  recognize	  the	  targets	  they	  have	  to	  let	  pass,	  for	  the	  misfolded	  proteins	  to	  be	  degraded	  are	  tagged	  by	  branched	  chains	  composed	   of	   a	   small	   protein	   called	   «	  ubiquitin	  ».	   The	   ubiquitin-­‐proteasome	  system	  can	  recognize	   the	  misfolded	  proteins	  because	   the	  alterated	  structure	  of	  the	   badly	   folded	   proteins	   transiently	   exposes	   degradation	   signals	   that	   aren’t	  exposed	  in	  the	  natural	  structure	  of	  the	  protein.	  The	  19S	  caps	  use	  ATP	  hydrolysis	  to	  unfold	  the	  polypeptide	  chains	  of	  the	  ubiquitin-­‐marked	  proteins	  and	  pass	  them	  on	  to	  the	  20S	  core	   for	  digestion	  to	  short	  peptides	  by	  proteolysis	  (Alberts	  at	  al.,	  4th	  edition,	  2002).	  
	  	   9	  
In	  short	  when	  a	  protein	  is	  synthesized,	  it	  can	  be	  either	  folded	  to	  the	  native	  state	  by	  the	  interaction	  of	  it’s	  hydrophobic	  parts	  with	  the	  new	  environment	  in	  which	  it’s	   transferred,	   folded	   or	   refolded	  with	   the	   help	   of	   a	  molecular	   chaperone,	   or	  incompletely	   folded	   or	  misfolded	   and	   hydrolyzed	   by	   the	   proteasome	   or	   create	  toxic	  aggregates	  with	  other	  misfolded	  proteins.	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  
Figure	  1:	  Model	  for	  the	  role	  of	  molecular	  chaperones	  in	  protein	  unfolding	  (from	  Hinault	  et	  
al.,	   2006).	   Under	   physiological	   conditions	   (upper	   path),	   an	   unfolded	   newly	   synthetized,	   or	  translocated	  polypeptide	  may	  spontaneously	  fold	  (1)	  into	  a	  native	  monomer,	  and/or	  (2)	  further	  assemble	   into	   an	   “alter-­‐native”	   discrete	   oligomer.	   ATPase	   unfolding	   chaperones	   can	   actively	  deoligomerize	   (-­‐2)	   “alter-­‐native”	   oligomers	   into	  monomers	   and	   further	  unfold	   (-­‐1)	  near-­‐native	  monomers	  to	  be	  translocated	  across	  membranes	  or	  degraded.	  Under	  stressful	  conditions	  (lower	  path),	   or	   because	   of	   mutations,	   a	   newly	   synthesized	   may	   spontaneously	   misfold	   (3)	   into	   a	  soluble,	  possibly	  toxic	  monomer,	  which	  may	  further	  assemble	  (4)	  into	  a	  continuum	  of	  small	  toxic	  oligomers	   that	   may	   further	   condense	   (5)	   into	   less	   toxic,	   compact	   amyloids.	   Specific	   organic	  molecules,	  may	  destabilize,	  and	  ATPase	  chaperones,	  actively	  scavenge	  (-­‐5,	  -­‐4)	  compact	  amyloids	  and	  fibbers	  into	  looser,	  albeit	  more	  toxic	  oligomers.	  ATPase	  chaperones	  may	  further	  unfold	  (-­‐3)	  and	  detoxify	  misfolded	  monomers	  into	  harmless	  protease	  products	  or	  natively	  refolded	  proteins.	  The	   leftward	   reactions	   are	   against	   entropy	   and	   ATP	   hydrolysis	   may	   be	   needed	   for	   the	  chaperones	   and	   proteases	   to	   forcefully	   unfold	   stably	  misfolded	   or	   alternatively	   folded	   protein	  structures.	  	  	  
Induction	  of	  chaperones	  and	  hsp’s	  by	  way	  of	  cellular	  membrane:	  Modifications	  in	  the	  plasma	  membrane	  itself	  such	  as	  hyperfluidization	  caused	  by	  local	   anesthetic	  benzyl	   alcohol	  and	  heptanol	  act	   as	  a	   signal	   to	   the	  activation	  of	  the	  HSP	  genes,	  thus	  initiating	  the	  whole	  heat	  shock	  protein	  response	  (Balogh	  et	  al.,	  2005).	  During	  a	  heat	  shock	  or	  when	  a	  cell	  is	  in	  an	  environmental	  stress,	  the	  activation	  of	  stress-­‐induced	  cell	   response	   is	  mediated	  by	   the	  heat	   shock	   transcription	   factor	  HSF-­‐1	  that	  acts	  as	  a	  key	  coordinator	   to	   the	  whole	  process.	  Figure	  2	  shows	  how	  HSF-­‐1	  is	  activated	  in	  such	  case	  and	  how	  the	  activation	  of	  this	  transcription	  factor	  triggers	  the	  heat	  shock	  proteins	  response.	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Figure	   2:	   Membrane	   Membrane-­‐mediated	   stress	   protein	   response	   and	   the	   cellular	  
localization	   of	   HSPs	   (highlighted	   by	   HSP70)	   in	   mammalian	   cells	   (from	   Horváth	   et	   al.,	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Caenorhabditis	  elegans:	  Saidi	   et	   al.	   used	   the	   Phycomitrella	   patens	  moss	   of	   the	   Funariaceae	   family	   as	   a	  biosensor	   for	   organic	   pollutants	   and	   also	   to	   see	   whether	   it	   could	   be	   use	   to	  produce	  a	  controlled	  amount	  of	  recombinant	  proteins	  through	  the	  activation	  of	  the	  soy	  bean	  heat	  shock	  promoter	  GmHSP17.3B	  (Saidi	  et	  al.,	  2005	  and	  2007).	  The	   model	   bacteria	   Escherichia	   coli	   has	   also	   been	   widely	   used	   in	   different	  experiments	   on	   the	   chaperone	   proteins.	   Chang	   et	   al.	   observed	   in	   E.coli	   the	  activity	   of	   DnaK	   chaperone	   protein,	   which	   belongs	   to	   the	   HSP70	   family	   and	  works	  together	  with	  DnaJ	  (also	  known	  as	  the	  previously	  mentioned	  HSP40).	  The	  ATPase	   activity	   of	   DnaK	   is	   indeed	   stimulated	   by	   the	   DnaJ	   co-­‐chaperone.	   The	  purpose	   of	   the	   study	   was	   to	   identify	   inhibitors	   of	   the	   DnaK/DnaJ	   complex.	  Flavonoids	  were	  found	  to	  bind	  DnaK,	  blocking	  allosterically	  interaction	  of	  DnaK	  with	   DnaJ	   (Chang	   et	   al.,	   2011).	   Wisén	   et	   al.	   used	   E.coli	   as	   well	   to	   identify	  compounds	   that	   could	   stimulate	   in	  vitro	   functions	   of	  DnaK.	  Dihydropyrimidine	  (115-­‐7c)	  was	   found	   to	   stimulate	   in	  vitro	  ATPase	   rate	   and	  protein	   folding,	   both	  major	  functions	  of	  DnaK.	  Wisén	   et	   al.	   used	   also	   Saccharomyces	   cerevisiae yeast	   to	   test	   whether	   115-­‐7c	  could	   compensate	   for	   the	   loss	   of	   YDJ1	   (ydj1Δ)	   in	   S.cerevisiae	   mutant.	   This	  mutation	   has	   been	   known	   to	   compromise	   severely	   ydj1Δ	   mutant’s	   growth	   at	  elevated	   temperature	   (Sell	   et	   al.,	   1990;	   Caplan	   et	   al.,	   1993;	   Sahi	   et	   al.,	   2007).	  Application	  of	  115-­‐7c	  100	  μM	  was	  found	  to	  greatly	  enhanced	  ydj1Δ	  cells’	  growth	  at	   34°C,	   an	   elevated	   temperature	   that	   normally	   causes	   the	  mutants’	   failure	   to	  thrive	  (Wisén	  et	  al.,	  2010).	  Studies	  on	  neurons	  directly	  have	  also	  been	  made.	  By	  observing	  the	  effect	  of	  body	  inclusions	   forming	  mutant	   huntingtin	   on	   rat	   or	  mouse	   pups’	   superior	   cervical	  ganglia	  neurons	  culture,	  King	  et	  al.	  discovered	  that	  it	  could	  suppress	  apoptosis	  in	  sympathetic	   neurons,	   being	   also	   refractory	   to	   proteasomal	   and	   lysosomal	  elimination	  (King	  et	  al.,	  2008).	  We	   choose	   in	   our	   study	   the	   Caenorhabditis	   elegans	   nematode	   as	   a	   model	   for	  polyQ	  disease.	  	  
Caenorhabditis	   elegans	   has	   been	   used	   already	   in	   many	   studies	   as	   a	   living	  organism	  to	  study	  the	  protein	  chaperones	  (such	  as	  Morley	  et	  al.,	  2002;	  Ben-­‐Zvi	  et	  al.,	  2009)	  
Caenorhabditis	  elegans	  is	  a	  nematode	  from	  the	  Rhabditidae	  family.	  It	  lives	  in	  the	  soil	  in	  most	  of	  the	  temperate	  regions	  of	  the	  world	  and	  an	  adult	  measures	  about	  1	  mm.	  The	   life	   span	   is	   about	   2-­‐3	  weeks	   and	   start	   producing	   eggs	   at	   3.5	   days.	   In	  case	   of	   hostile	   environment	   it	   can	   become	   a	   «	  dauer	  »,	   transforming	   itself	   in	   a	  more	  resistant	  form,	  even	  resisting	  to	  desiccation.	  The	  dauer	  form	  does	  not	  age.	  	  C.elegans	   can	   be	   either	   male	   or	   hermaphrodite.	   The	   males	   can	   produce	   only	  sperm,	  with	  which	   they	  can	   fertilize	   the	  oocytes	  of	   the	  hermaphrodites.	  This	   is	  called	   cross-­‐fertilization.	   Unlike	   the	   males,	   the	   hermaphrodites	   can	   produce	  sperm	   and	   oocytes	   allowing	   them	   to	   self-­‐fertilize	   themselves.	   The	   sperm	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produced	   by	   males	   outcompete	   the	   sperm	   of	   hermaphrodites	   so	   cross-­‐fertilization,	   that	   produces	   either	   males	   or	   hermaphrodites	   in	   the	   same	  proportion,	   is	   more	   frequent	   than	   self-­‐fertilization	   that	   can	   only	   produce	  hermaphrodites	   (Hope,	  1999).	  The	  possibility	  of	   controlling	   these	   two	   types	  of	  gene	   heredity	   by	   choosing	   the	   cross-­‐fertilization	   or	   the	   self-­‐fertilization	   made	  
C.elegans	   an	   easy	   model	   to	   produce	   mutants,	   especially	   for	   producing	  homozygous	   animals	   carrying	   recessive	   mutations	   by	   using	   self-­‐fertilization.	  This	   is	   the	  main	  reason	  why	  one	  of	   the	  main	   field	   in	  which	  C.elegans	  was	  used	  was	   genetics,	   especially	   in	   genome	   sequencing	  projects	   (Science	  N°282,	   1998).	  	  	  
C.elegans	   only	   requires	   for	   growth	   and	   reproduction	   a	   humid	   environment,	   an	  ambient	   temperature,	   atmospheric	   oxygen	   and	   a	   lawn	   of	   bacteria	   for	   food,	  explaining	  why	  it	  can	  be	  a	  model	  of	  choice	  as	  it’s	  rather	  cheap	  and	  easy	  to	  fulfill	  these	  few	  conditions.	  What	  interests	  us	  here	  are	  the	  advantages	  presented	  by	  C.elegans	  for	  the	  study	  of	  polyQ	  disease	  and	  chaperone	  proteins.	  Indeed,	   unlike	   in	   humans	  where	   toxic	   polyQ-­‐mutant	   proteins	   aggregate	   in	   the	  neurons,	  polyQ	  disease	  in	  C.elegans	  can	  be	  made	  to	  express	  itself	  in	  the	  body	  wall	  muscle	   cells	   causing	  motility	   impairment.	   This	   is	   an	   appreciable	   fact,	   allowing	  the	   quantification	   of	   severity	   of	   polyQ	   disease’s	   expression	   by	   observing	   or	  monitoring	  the	  motility	  of	  polyQ	  mutant	  C.elegans.	  Morley	  et	  al.	  who	  studied	  the	  length-­‐dependent	  threshold	  for	  aggregation	  and	  toxicity	  of	  polyQ	  proteins	  have	  used	   this	   particularity.	   Not	   only	   did	   they	   establish	   the	   link	   between	   polyQ	  disease	   expression	   and	   the	   length	   of	   the	   polyglutamine	   stretch	   but	   they	   also	  found	   that	   aging	   had	   a	   negative	   impact	   on	   the	   stress-­‐induced	   response	   by	   the	  chaperone	   proteins,	   as	   it	   has	   on	   human	   Huntington’s	   disease	   development	  (Morley	  et	   al.,	   2002).	  The	  way	  aging	  negatively	   influences	   the	  above	  described	  defense	  mechanisms	  used	  to	  avoid	  misfolded	  proteins	  aggregation	  may	  explain	  why	   the	   onset	   of	  most	   neurodegenerative	   diseases	   is	   at	  mid-­‐age	   or	   older	   and	  usually	  not	  in	  the	  childhood,	  where	  chaperone	  proteins’	  expression	  is	  maximal.	  Thus	  C.elegans	   is	  an	  animal	  model	  that	  can	  express	  in	  an	  easily	  observable	  way	  polyQ	   disease	   by	   observing	   the	   protein	   aggregates	  marked	  with	   GFP,	   and	   is	   a	  model	  where	  aging,	  an	  easily	  controlled	  factor,	  exacerbates	  the	  toxic	  aggregation	  in	   the	   cells,	   making	   C.elegans	   a	   model	   of	   choice	   for	   the	   study	   of	   the	   polyQ	  diseases.	  	  
The	   hydroxylamine	   derivative	   NG-­‐094	   suppresses	   paralysis	   in	  
Caenorhabditis	  elegans	  (Haldimann	  et	  al.,	  2011):	  This	  present	  study	  is	  the	  follow-­‐up	  of	  a	  previous	  study	  by	  Haldimann	  et	  al.,	  2011.	  They	  used	  genetically	  modified	  C.elegans	  expressing	  in	  body	  wall	  muscle	  cells	  a	  toxic	  mutant	  protein	  containing	  a	  35	  CAG	  repeat	  sequence	  and	  tested	  NG-­‐094	  a	  novel	   hydroxylamine	   derivative	   on	   life	   span	   and	   on	   the	   progression	   of	   the	  impairment	   of	   motility.	   The	   recombinant	   protein	   was	   fused	   to	   the	   yellow	  fluorescent	  protein	  (YFP)	  allowing	  visualization	  by	  fluorescence.	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As	  we	   said	   before,	   the	   expression	   of	   polyQ	   diseases	   is	   polyQ-­‐length-­‐	   and	   age-­‐dependent	   (Morley	  et	  al.,	  2002).	  Thus	   the	   first	   step	  of	  Haldimann’s	  experiment	  was	   to	   observe	   changes	   in	   C.elegans’	   motility	   influenced	   by	   different	  physiological	  temperatures	  from	  15°C	  to	  25°C.	  To	  assess	  motility	  of	  nematodes,	  100-­‐200	  age-­‐synchronized	  C.elegans	  were	  placed	  at	  the	  center	  of	  a	  plate	  where	  was	  previously	  deposited	  a	  3-­‐5mm	  thick	  ring	  circle	  made	  of	  E.coli	  OP50	  strain	  of	  about	  3.5	  cm	  in	  diameter	  to	  attract	  the	  nematodes	  by	  chemotaxy.	  After	  60	  min,	  nematodes	  that	  reached	  the	  OP50	  strain	  were	  counted.	  Nematodes	  were	  grown	  for	  three	  days	  since	  hatching	  at	  the	  mentioned	  temperature	  before	  the	  motility	  assays.	  At	   temperature	   until	   20°C,	   polyQ35	   nematodes	   and	   polyQ0	   had	   a	   similar	  motility,	  nearly	  the	  same	  percentage	  of	  both	  groups	  could	  reach	  the	  OP50	  circle.	  Spectacular	  loss	  of	  motility	  was	  observed	  at	  21°C	  and	  22°C,	  where	  25%	  and	  50%	  of	   polyQ35	   respectively	   couldn’t	   reach	   the	   target.	   At	   24°C	   just	   a	   few	   polyQ35	  nematodes	  could	  reach	  the	  target	  and	  none	  could	  do	  so	  at	  25°C	  (See	  figure	  3).	  	  
	  
Figure	  3:	  Motility	  assays	  for	  three-­‐days	  old	  grown	  nematodes	  at	  different	  temperatures.	  At	  21°C	  25%	  of	   polyQ35	   couldn’t	   reach	   the	   target	   after	   an	   hour,	   50%	   at	   22°C.	   At	   higher	   temperatures,	   motility	  impairment	  is	  even	  greater.	  (From	  Haldimann	  et	  al.,2011)	  Aggregation	   of	  misfolded	   proteins	   in	   body	  wall	  muscle	   cells	  was	   evaluated	   by	  observing	  mutant	  protein	  fused	  to	  YFP	  aggregates	  with	  fluorescence	  microscopy.	  Direct	  proportionality	  between	  temperature	  and	  quantity	  of	  aggregates	  has	  been	  observed	  (see	  figure	  4).	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  Figure	   4:	   Visualization	   of	   polyQ35	   protein	   aggregates	   by	   fluorescence	   microscopy.	   Quantity	   and	  importance	   of	   aggregates	  were	  more	   elevated	   for	   nematodes	   grown	   at	   25°C	   than	   at	   20°C,	   showing	   how	  temperature	  affects	  the	  development	  of	  polyQ	  disease	  in	  transgenic	  C.elegans.	  Homogeneous	  glow	  of	  GFP	  is	  replaced	  by	  easily	  observable	  pathological	  aggregates,	  at	  25°C	  even	  more	  than	  at	  20°C.	  (From	  Haldimann	  et	  al.,	  2011)	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The	   study	   showed	   that	   polyQ35	   were	   more	   sensitive	   to	   mildly	   elevated	  temperature	   during	   growth	   and	   that	   high	   temperatures	   accelerated	   the	   polyQ	  protein	  aggregation	  and	  more	  widely	  exacerbated	  polyQ	  mediated	  cytotoxicity.	  They	  also	  compared	  the	  two	  negatively	  impacting	  factors	  aging	  and	  temperature.	  Motility	  of	  polyQ0	  nematodes	  was	  reduced	  by	  50%	  either	  after	  9	  days	  at	  20°C	  or	  after	  6	  days	  at	  24°C.	  PolyQ35	  animals’	  motility	  was	  reduced	  by	  50%	  after	  7	  days	  at	   20°C	   or	   after	   3	   days	   at	   22°C	   (or	   higher	   temperatures).	   Thus	   elevated	  temperature	   during	   growth	   accelerates	   the	   age-­‐dependent	   loss	   of	   motility,	  validating	   that	  C.elegans	   has	  a	   shorter	   life	   span	  at	  higher	   temperatures	   than	  at	  lower	  temperatures	  (Hirsh	  et	  al.,	  1976).	  Both	  negative	  impact	  of	  aging	  and	  high	  temperature	  growth	  lead	  to	  the	  idea	  that	  environmental	  factors	  that	  exacerbate	  the	   need	   for	   optimal	   protein	   quality	   control	   by	   increasing	   the	   demand	   of	   the	  misfolded	   protein	   system	   may	   increase	   greatly	   the	   severity	   of	   Polyglutamine	  diseases.	  Core	   of	   the	   study	   was	   the	   test	   of	   novel	   hydroxylamine	   derivative	   NG-­‐094	   on	  polyQ35	   nematodes.	   They	   compared	   polyQ0	   animals	   for	   control	  with	   polyQ35	  nematodes	   grown	   at	   22°C	   for	   three	   days,	   conditions	   that	   showed	   motility	  impairment	   in	  50%	  of	   transgenic	  polyQ35	  nematodes.	  Treatment	  with	  NG-­‐094	  improved	  the	  motility	  of	  polyQ35	  nematodes	  in	  a	  dosage	  dependent	  manner	  (see	  
figure	  5).	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	   5:	  NG-­‐094	   treatment	   increased	   motility	   index	   in	   polyQ35	   nematodes	   in	   a	   dose-­‐
dependent	  manner.	  (From	  Haldimann	  et	  al.,	  2011)	  
	  
Figure	  5	  also	  shows	  that	  at	  high	  concentration	  NG-­‐094	  had	  a	  deleterious	  effect	  on	  polyQ0	   nematodes.	   1mM	   in	   the	   growth	   medium	   was	   chosen	   to	   be	   the	  concentration	   of	   NG-­‐094	   to	   be	   tested,	   as	   it	   had	   a	   great	   benefit	   on	   polyQ35	  animals’	   motility	   without	   a	   too	   important	   loss	   in	   polyQ0	   nematodes’	   motility	  index.	  Motility	   assays	   showed	  many	  different	  properties	  of	  NG-­‐094.	  Not	  only	  did	  NG-­‐094	   treatment	   have	   positive	   effect	   on	   loss	   of	   mobility	   in	   polyQ0	   wild	   type	  nematodes	   suggesting	   an	   anti-­‐aging	   property,	   but	   also	   could	   slow	   the	   disease	  progression	  after	  the	  onset	  of	  the	  disease	  which	  is	  most	  important	  as	  usually	  the	  patients	  discover	  their	  disease	  once	  they	  start	  to	  express	  themselves	  clinically.	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Motility	  tests	  for	  drugs	  preventing	  PolyQ	  aggregation	  in	  
recombinant	  Caenorhabditis	  elegans:	  	  In	   this	   general	   context	   this	   study	   aims	   to	   identify	   least	   toxic	   drugs	   that	   can	  upregulate	   the	   expression	   of	   chaperone	   genes	   in	   body	   muscle	   cells	   suffering	  from	  PolyQ-­‐mediated	  protein	  aggregation	  and	  degeneration.	  First	  part	  consisted	  in	  a	  screening	  of	  10	  selected	  drugs	  to	  observe	  whether	  they	  could	   improve	  the	  motility	   impairment	   of	   PolyQ35	   nematodes	   or	   not.	   Second	   part	   of	   the	   study	  focuses	  on	  the	  most	  promising	  drug	  following	  screening,	  piroxicam.	  	  
Material	  and	  Methods	  
	  
Drugs:	  The	   ten	   drugs	   (see	   table	  3)	   used	   in	   the	   study	  were	   selected	   by	   our	   laboratory	  after	   having	   made	   a	   wide	   screening	   on	   2000	   drugs	   to	   find	   some	   that	   could	  overexpress	  or	  inhibit	  heat	  shock	  response	  in	  moss	  Physcomitrella	  patens	  (used	  database:	  The	  Spectrum	  Collection	  2000	  MicroSource).	  Drugs	  were	  provided	   in	  DMSO	  10mM.	  Warfarin,	  ursodiol,	  piroxicam	  and	  undecyclenic	  acid	  are	  the	  drugs	  that	  have	  shown	  greatest	  effect	  in	  prior	  mentioned	  wide	  screening.	  
	  
Drug	   Known	  effects	   Chemical	  structure	  
Warfarin	   Anticoagulant,	  Rodenticide	   	  
Ursodiol	   Anticholelithogenic	   	  
Piroxicam	   Antiinflammatory,	  analgesic,	  antipyretic	  (NSAID’s)	   	  
Undecyclenic	  
Acid	   Antifungal	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Anisindione	   Anticoagulant	   	  
Chlorambucil	   Antineoplastic	  (alkylating	  agent)	   	  
Flurbiprofen	   Antiinflammatory,	  analgesic,	  antipyretic	  (NSAID’s)	   	  
Disulfiram	   Alcohol-­‐Dehydrogenase	  enzyme	  inhibitor	   	  
Diclofenac	  
Sodium	  
Antiinflammatory,	  analgesic,	  antipyretic	  (NSAID’s)	   	  
Fenbufen	   Antiinflammatory,	  analgesic,	  antipyretic	  (NSAID’s)	   	  
Table	  3:	  The	  ten	  drugs	  tested	  in	  the	  motility	  assays.	  The	  ten	  drugs	  were	  chosen	  among	  2000	  drugs	  in	  a	  large	  screening	  on	  the	  Spectrum	  Collection	  2000	  MicroSource	  database,	  according	  to	  their	  activating	  and	   inhibiting	  effect	  on	  chaperone	  proteins.	  The	   four	   first	  drugs	  were	   the	  ones	  showing	  best	  results	  in	  the	  screening.	  
	  
Antibiogram	   test	   showed	   no	   antibacterial	   property.	   As	   C.elegans	   needs	  bacterial	   feeding	   in	   order	   to	   grow	   and	   survive,	   we	   were	   interested	   whether	  bacterial	  OP	  50	  lawn	  was	  able	  to	  grow	  in	  the	  medium	  containing	  drugs.	  In	  order	  to	   do	   so	   we	   performed	   prior	   to	   the	   motility	   assays	   an	   antibiogram	   using	   LB	  medium	  (Bacto	  agar	  17g/l	  and	  Difco	  LB	  Broth	  25g/l).	  Each	  drug	  was	  tested	  at	  7	  different	  concentrations	  containing	  always	  1%	  of	  DMSO	  (DMSO	  1%	  was	  common	  denominator	   in	  medium	   composition	   during	   the	   first	   part	   of	   the	   experiment):	  1μM,	  3	  μM,	  10	  μM,	  30	  μM,	  100	  μM,	  300	  μM	  and	  1mM.	  Dishes	  were	  place	  at	  37°C	  for	  a	  few	  days	  and	  none	  of	  the	  drugs	  showed	  an	  antibacterial	  property.	  Control	  plate	  containing	  100	  μg/ml	  of	  Ampicillin	  inhibited	  bacterial	  growth.	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Caenorhabditis	  elegans:	  	  
C.elegans	   strains.	   The	   strains	   used	   for	   the	   experiment	   were	   expressing	   a	   35	  CAG	  polyglutamine	  expansion	  and	  fused	  to	   the	  green	   fluorescent	  protein	  (GFP)	  in	   body	   wall	   muscles	   cells.	   The	   polyQ-­‐GFP	   expressing	   strains	   are:	   PolyQ0	   –	  AM134[rmIs126(Punc-­‐54::q0::yfp)]	   and	   PolyQ35	   –	   AM140[rmIs132(Punc-­‐
54::q35::yfp)].	  The	  strains	  used	  in	  this	  study	  are	  the	  same	  used	  by	  Haldimann	  for	  his	  study	  with	  NG-­‐094	  (Haldimann	  et	  al.,	  2011)	  
	  
Culture	   of	  C.elegans.	  Culturing	  and	  maintenance	  of	  C.elegans	  were	  performed	  according	  to	  standardized	  methods	  (Brenner,	  1974).	  Nematodes	  were	  grown	  on	  nematode	   growth	   media	   (NGM)	   dishes	   with	   Escherichia	   coli	   OP50	   layer	   for	  feeding,	  placed	  in	  an	  incubator	  at	  20°C.	  To	  avoid	  lack	  of	  food	  or	  space,	  transfers	  were	  made	  each	  3-­‐4	  days	  by	  placing	  an	  approximately	  4mm	  long	  square	  of	  NGM	  medium	  dish	  on	  which	  nematodes	  were	  growing	  into	  a	  new	  NGM	  Petri	  dish	  with	  grown	  OP50	  layer.	  	  
Synchronization.	  Prior	  to	  motility	  assays,	  nematodes	  were	  age-­‐synchronized	  to	  avoid	   age-­‐related	   motility	   bias	   and	   to	   have	   the	   most	   homogenous	   sample	  possible.	   In	   order	   to	   isolate	   embryos	   from	   gravid	   adults,	   we	   collected	   all	  
C.elegans	  from	  a	  Petri	  dish	  used	  for	  stock	  and	  growth	  and	  treated	  with	  solution	  containing	  equal	  volume	  of	  1mM	  sodium	  hydroxide	  and	  5%	  sodium	  hypochlorite	  for	  8	  minute.	  Embryos	  were	  then	   laid	  on	  NGM	  dish	  with	  OP50	  (see	  protocol	   in	  appendix	   1).	   In	   the	   experiments	   where	   age-­‐synchronized	   nematodes	   were	  employed,	  NGM	  medium	  was	  containing	  drug	  in	  appropriate	  concentration.	  	  	  
Motility	   assays.	   Prior	   to	   motility	   assays,	   age-­‐synchronized	   nematodes	   were	  placed	  on	  NGM	  medium	  containing	  tested	  drug	  in	  appropriate	  concentration	  for	  3	   days	   at	   22°C.	   This	   temperature	  was	   chosen	   following	   Haldimann’s	   protocol,	  allowing	  a	  50%	  loss	  of	  motility	  index	  in	  polyQ35	  population	  (Haldimann’s	  et	  al.,	  2010).	  For	  the	  motility	  assays,	  age-­‐synchronized	  strains	  treated	  with	  drugs	  were	  collected	  with	  pipette	  in	  small	  1.5	  ml	  tubes	  by	  rinsing	  dish	  where	  they	  grew	  with	  sterilized	  M9	  solution (3	  g	  KH2PO4,	  6	  g	  Na2HPO4,	  5	  g	  NaCl,	  1	  ml	  1	  M	  MgSO4,	  H2O	  to	   1	   liter	   and	   sterilized	   by	   autoclaving.)	   With	   10μl	   pipette,	   between	   5-­‐10	  nematodes	  were	  then	  placed	  in	  the	  middle	  of	  35	  x	  10	  mm	  Petri	  dishes	  containing	  a	   thicker	   and	  more	   concentrated	  OP50	   layer	   so	   that	   the	   traces	   could	  be	   easily	  spotted.	  Drop	  containing	  the	  nematodes	  was	  spread	  by	  moving	  the	  dish	  carefully	  in	  different	  angles.	  This	  was	  made	  to	  avoid	  the	  agglutination	  of	  nematodes,	  that	  would	   otherwise	   impair	   nematode	   movement	   during	   recording	   time	   and	   to	  allow	  M9	  solution	  to	  dry	  up	  faster.	  Images	  of	  the	  traces	  were	  taken	  15	  minutes	  after	  drop	  was	  deposited	  in	  recording	  dish.	  During	  this	  time	  dishes	  were	  placed	  back	  in	  the	  incubator	  at	  22°C	  to	  avoid	  ambient	  temperature	  stress.	  Control	  with	  polyQ35	   or	   polyQ0	   grown	   in	   same	   environmental	   conditions	  was	  made	   every	  day	  of	  assays	  to	  avoid	  unnecessary	  biological	  bias.	  Minimally	  3	  dishes	  per	  drug	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were	  used	  and	   recorded	   for	   first	   screening	  and	  about	  10	  dishes	  were	  used	   for	  each	  treated	  or	  control	  strain	  in	  second	  part	  of	  the	  study.	  
	  
Boxplot	   diagrams.	   Descritpive	   statistics	   has	   been	   presented	   through	   boxplot	  diagrams.	  Boxplot	  graphs	  were	  made	  using	  Microsoft	  Office	  2011	  Excel	  program	  (from	  http://www.bloggpro.com/box-­‐plot-­‐for-­‐excel-­‐2007/).	  Middle	  line	  of	  the	  box	  represents	   the	   median,	   the	   top	   line	   the	   3rd	   quartile	   and	   the	   bottom	   line	  represents	   the	   1st	   quartile.	   The	   vertical	   lines	   show	   the	   maximum	   and	   the	  minimum	   values,	   regarding	   to	   their	   top	   or	   bottom	   position.	   This	   format	   of	  presentation	   allows	   an	   objective	   view	   on	   the	   results	   with	   no	   modification	   of	  numbers	  for	  statistical	  purposes.	  	  
Concentrations.	   In	   the	   first	   part	   of	   the	   experience	  NGM	  mediums	   for	   treated	  
C.elegans	  were	  all	  at	  the	  concentration	  of	  64μM	  of	  drugs	  and	  dimethyl	  sulfoxyde	  1%	  (DMSO	  1%).	  For	  second	  part,	  NGM	  was	  at	  32μM	  or	  64μM	  of	  piroxicam	  and	  chloroform	   (CHCl3)	   0.1%	   replaced	   DMSO	   1%.	   Control	   groups	   were	   grown	   on	  regular	  NGM	  medium	  in	  same	  environmental	  conditions.	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Figure	  6:	  
	  
A.	  	  Fusing	  pictures:	  	  	  1.	  Recorded	  images	  were	  assembled	  together	  in	  a	  single	  one	  showing	  all	  the	  nematode	  traces	  on	  the	  dish	  used	  for	  the	  motility	  assays.	  The	  image	  below	  shows	  the	  fused	  pictures	  composing	  an	  image	  of	  the	  whole	  dish.	  4-­‐5	  pictures	  were	  needed	  for	  each	  dish.	  	  
	  	  	  	  	  	  
B.	  	  Obtaining	  the	  scale:	  
	  
	  1.	  When	  taking	  pictures	  with	  Leica	  Application	  Suite	  program,	  configure	  the	  image	  so	  that	  a	  scale	  as	  shown	  appears:	  
	  	  2.	  	  With	  ImageJ	  program,	  draw	  a	  segment	  that	  appears	  to	  be	  1	  mm	  according	  to	  the	  scale:	  
	  	  	  	  	  	  
	  
	  
The	  bar	  in	  the	  top	  right	  corner	  is	  the	  
first	   half	   of	   the	   application	   bar	   of	  
ImageJ.	   Selected	   button	   is	   the	   one	  
that	  draws	  the	  segment.	  
Pictures	   were	   joined	   to	  
allow	  easier	  measurement	  
with	   NeuronJ	   plugin.	   You	  
can	   recognize	   the	   round	  
petri	  dish	  by	  looking	  at	  the	  
edges.	  
	  Petri	  dish	  edge	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3.	  	  By	  selecting	  «	  Set	  Scale	  »	  (see	  fig	  3a),	  find	  out	  the	  number	  of	  pixels	  needed	  to	  complete	  the	  scale	  and	  thus	  1	  mm	  (here	  51	  pixels	  for	  1mm,	  appearing	  in	  blue	  in	  fig	  3b).	  	  3a.	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  3b.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
C.	  Traces	  measurements:	  1.	  	  Open	  the	  picture	  with	  NeuronJ	  plugin,	  and	  draw	  your	  lines	  following	  the	  traces	  of	  C.elegans	  on	  OP50	   layer.	   As	   only	   the	   total	   length	   interests	   us,	   you	   can	   draw	   as	  many	   different	   lines	   as	   you	  want	  to	  cover	  the	  whole	  nematodes’	  traces.	  	  2.	   	  By	   choosing	  «	  set	   scale	  »	   in	  NeuronJ	  again	   (see	   fig	  2a),	   you	  can	  set	   the	  proper	   scale.	  For	  51	  pixels/mm,	  which	  is	  appropriate	  for	  our	  example,	  fill	  the	  fields	  as	  shown	  in	  fig	  2b.	  	   2a.	  	  	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2b.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  3.	  	  Select	  “Measure	  Tracings”	  to	  obtain	  final	  length	  of	  total	  traces	  (you	  will	  get	  a	  total	  length	  of	  all	  the	  nematodes	  traces	  and	  not	  a	  length	  of	  individual	  traces.).	  In	  “Sum	  Len	  (mm)”	  of	  	  “NeuronJ:Groups”	  window,	  the	  presented	  value	  is	  used	  in	  results	  and	  in	  graphs.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	  6:	   Step	   by	   step	   explanation	   of	   tracks	   measurements.	   (A)	   Pictures	  were	   fused	  with	  Adobe	  III	  Illustrator	  CS5	  for	  easier	  measurement	  of	  tracks	  with	  NeuronJ	   (B)	  Obtaining	  scale	  by	  using	  ImageJ.	  NeuronJ	  plugin	  is	  not	  needed	  for	  this	  step.	  (C)	  Measure	  tracks	  with	  NeuronJ	  plugin	  after	  having	  configured	  the	  scale.	  Length	  of	  traces	  obtained	  is	  the	  value	  of	  the	  whole	  dish.	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Images	  of	  polyQ	  proteins	  aggregates	  with	  fluorescence	  microscopy.	  Images	  of	  C.elegans	  with	   protein	   aggregates	  were	   taken	  with	   fluorescence	  microscopy	  using	  a	  LEICA	  DM	  5500	  B	   to	  verify	  whether	  we	  could	  establish	  a	   link	  between	  improvement	  of	  motility	  and	  quantity	  and	  size	  of	  toxic	  polyQ	  protein	  aggregates.	  	  
Results	  
Anisindione	   and	   Piroxicam	   show	   best	   improvement	   of	   motility	   in	  
screening.	   Screening	   permitted	   to	   isolate	   two	   of	   the	   drugs	   as	   potentially	  interesting	   for	   overexpressing	   chaperone	   proteins.	   Anisindione	   and	   Piroxicam	  showed	  an	  improvement	  in	  polyQ35	  nematodes’	  motility,	  respectively	  increasing	  the	  mean	   length	  of	   tracks	  of	  22.7%	  and	  27%.	  Q35	  had	  a	  24.5%	  reduced	  mean	  length	   of	   tracks	   compared	   to	  Q0,	   so	   anisindione	   and	   piroxicam	   could	   improve	  polyQ35	  nematodes’	  motility	   nearly	   to	   the	   result	   of	  Q0	   values	   or	   even	  may	  be	  slightly	  higher	   it	   in	   the	   case	  of	  piroxicam.	  Figure	  7	   shows	   the	   raw	   results	  with	  boxplots	  of	  the	  length	  of	  tracks	  of	  the	  nematodes	  according	  to	  their	  treatment.	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DMSO	   1%	   suspected	   of	   being	   directly	   toxic	   to	   C.elegans	   and/or	   having	   a	  
negative	  impact	  on	  polyQ	  disease	  expression.	  DMSO	  1%	  showed	  a	  reduction	  of	  22%	  in	  polyQ35’s	  mean	  length	  of	  tracks	  (see	   figure	  7),	  suggesting	  a	  negative	  impact	  on	  polyQ	  disease	  development	   and	  expression.	   It	   also	   showed	  a	   loss	  of	  motility	  of	  45.1%	  on	  polyQ0	   (see	   figure	  9)	   Since	  all	   the	  NGM	  medium	  used	   for	  growth	  contained	  DMSO	  1%	  along	  with	  the	  drug,	  DMSO	  might	  have	  enhanced	  the	  toxic	  effect	  of	  some	  drugs,	  explaining	  partly	  the	  elevated	  toxicity	  that	  some	  drugs	  like	   fenbufen	   and	   ursodiol	   had	   in	   the	   screening.	   Considering	   DMSO	   potential	  toxicity,	  piroxicam	  and	  anisindione	  could	  be	  even	  more	  potent	  drugs	  for	  polyQ35	  nematode	  motility	  improvement.	  As	  in	  the	  piroxicam	  trial	  using	  0.1%	  chloroform	  (CHCl3)	   instead	   of	   1%	   DMSO	   to	   dilute	   piroxicam	   didn’t	   show	   a	   better	  improvement	   of	   Q35,	   it	   is	   possible	   that	   piroxicam	   may	   interact	   with	   DMSO	  molecule	   or	   prevent	   its	   toxicity.	   It	   is	   also	   possible	   that	   maximum	   benefit	   on	  motility	  was	  obtained	  with	  piroxicam	  and	  that	  presence	  of	  DMSO	  1%	  or	  CHCl3	  did	  not	  matter	  much.	  
	  
Piroxicam	   greatly	   improves	   motility	   of	   polyQ35	   nematodes	   in	   a	   dose-­‐
dependent	   like	  manner.	  32	  μM	  piroxicam	   improved	  mean	   length	  of	   tracks	  of	  9.0%	   and	   piroxicam	   64	   μM	   of	   32.3%.	   The	   motility	   of	   healthy	   nematodes	   was	  33.6%	   better	   than	   the	   motility	   of	   sick	   nematodes	   (the	   mean	   length	   of	   traces	  results	   were	   calculated	   but	   cannot	   be	   seen	   in	   the	   boxplot	   diagrams).	   	   These	  results	  suggest	  that	  piroxicam	  could	  restore	  impaired	  motility	  of	  sick	  nematodes	  in	  a	  dose	  dependent	  response	  near	  completion.	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Figure	   8:	  Results	   of	   motility	   assays	   with	   piroxicam	   showing	   a	   dose-­‐dependent	   relation	   between	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Chloroform	  a	  better	  solvent	  than	  DMSO	  1%.	  To	  verify	  whether	  1%	  DMSO	  had	  a	   direct	   toxicity	   on	  C.elegans,	  we	   also	   tested	   1%	  DMSO	  on	  Q0	  wild	   type	   strain	  (see	   figure	  9)	   that	   resulted	   in	   a	   loss	   of	   Q0	   nematode	  motility	   of	   45.1%.	  When	  0.1%	  chloroform	  was	  used	  as	  a	  replacement	  of	  1%	  DMSO	  for	  diluting	  piroxicam,	  we	   observed	   a	   loss	   of	   Q0	   nematode	   motility	   of	   only	   5.1%.	   DMSO	   had	   to	   be	  replaced	  because	  of	  its	  toxicity	  suspicion	  but	  also	  because	  dilution	  of	  piroxicam	  was	   impossible	   without	   precipitation	   in	   DMSO	   (Drugs	   were	   provided	   already	  diluted	   in	   DMSO	  when	   received	   in	   the	   lab	   for	   screening).	   This	   result	   suggests	  that	   chloroform	   has	   a	   lesser	   toxicity	   on	   C.elegans	   and	   should	   be	   preferred	   to	  DMSO	  if	  possible.	  	  
Piroxicam	   may	   be	   toxic	   or	   interfere	   with	   wild	   type	   C.elegans’	   growth	  
development	   or	   behavior.	   64	  μM	  piroxicam	  was	   also	   tested	  on	  wild	   type	  Q0	  nematodes	   for	   control,	   causing	   a	   loss	   of	   healthy	   nematode	   motility	   of	   44.3%	  Therefore	  we	   conclude	   that	   piroxicam	   had	   a	   powerful	   effect	   on	   both	   sick	   and	  healthy	  strains	  of	  C.elegans,	  allowing	  great	  recovery	  in	  sick	  nematodes	  and	  great	  toxicity	   in	   healthy	   ones.	   This	   surprising	   negative	   effect	   on	   motility	   of	   healthy	  nematodes	  will	  be	  further	  discussed	  in	  discussion.	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Images	   of	   polyQ	   protein	   aggregates	   by	   fluorescence	  microscopy.	   PolyQ35	  nematodes	  without	  treatment	  or	  treated	  with	  piroxicam	  seem	  to	  have	  the	  same	  quantity	   of	   polyQ	   aggregates,	   even	   though	   treatment	   with	   piroxicam	   greatly	  improved	  the	  motility	  of	  sick	  nematodes.	  	  
	  	  	  	  A.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  B.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  C.	  
	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	  10:	  Images	  of	  polyQ	  protein	  aggregates	  of	  Q0,	  Q35	  and	  Q35	  treated	  with	  piroxicam	  
by	   fluorescence	   microscopy.	   (A)	   Q0	   healthy	   nematode	   with	   a	   homogeneous	   glow	   of	   GFP	  proteins.	  (B)	  PolyQ35	  nematode:	  Homogeneous	  glow	  is	  modified	  by	  the	  presence	  polyQ	  proteins	  aggregates.	  (C)	  PolyQ35	  aggregates	  of	  sick	  nematodes	  treated	  with	  piroxicam	  didn’t	  show	  clear	  difference	  in	  quantity	  than	  of	  the	  untreated	  polyQ35	  nematodes.	  
	  
Discussion	  	  At	   first	   this	   study	   was	   supposed	   to	   follow	   the	   method	   of	   Haldimann	   and	  colleagues	  (Haldimann	  et	  al.,	  2011).	  Using	  proclaimed	  method,	  being	  for	  a	  great	  part	  operator	  dependent,	  similar	  results	  were	  hard	  to	  obtain	  with	  conceded	  time.	  According	   to	   Haldimann,	   many	   months	   were	   needed	   to	   get	   stable	   and	  reproducible	  results.	  By	  employing	  the	  same	  protocol	  for	  nematode	  maintenance	  and	   with	   an	   operator	   that	   took	   part	   in	   some	   of	   the	   motility	   assays’	   of	  Haldimann’s	   study,	  our	   results	  were	   found	   to	  be	  different.	  Motility	  assays	  with	  nematodes	  grown	  at	  24°C	  did	  not	  even	  show	  a	   loss	  of	  motility	   index	  similar	   to	  the	   one	   for	   nematodes	   grown	   at	   22°C	   according	   to	   Haldimann’s	   results.	   An	  important	   part	   of	   the	   allowed	   time	   was	   spent	   trying	   to	   apply	   Haldimann’s	  method	  and	  find	  similar	  differences	  between	  polyQ35	  nematodes	  and	  wild	  type	  Q0	  nematodes	  without	  success.	  This	  encouraged	  us	  to	  find	  an	  alternative	  way	  to	  measure	   the	  motility	  of	  polyQ35	   transgenic	  nematodes.	  We	  believe	   the	   chosen	  method	   described	   above	   has	   the	   qualitative	   advantage	   of	   recording	   more	  precisely	   the	   treated	  nematodes’	  motility	  with	   a	   less	   time-­‐consuming	  protocol.	  Indeed	  Haldimann’s	  experiment	   took	   in	  account	  whether	  sick	  nematodes	  could	  reach	   a	   goal	   after	   a	   chosen	   length	   of	   time	   or	   not,	   but	   it	   didn’t	   take	   in	   account	  whether	   nematodes	   lost	   their	   sensitivity	   to	   chemotaxy	   and/or	   just	   randomly	  moved	   without	   reaching	   the	   circle	   of	   OP50	   while	   keeping	   physically	   the	  opportunity.	  	  The	  greatest	  advantage	  is	  that	  you	  can	  record	  precisely	  the	  length	  of	  the	  traces	  left	   behind	  by	   the	  nematodes,	   being	   able	   to	  observe	   also	   its	  way	  of	  moving	  by	  looking	  at	  the	  quality	  of	  tracks	  left	  by	  the	  movement	  they	  make	  to	  move.	  This	  can	  provide	  good	   information,	   like	  whether	   the	  nematode	   is	   injured	  and	  should	  be	  removed	   of	   the	   analysis	   or	   if	   it	   is	   in	   good	   health	   and	   moves	   with	   adequate	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movements.	   Downside	   is	   that	   the	   sample	   is	   rather	   small,	   with	   about	   10	  nematodes	  per	  dishes,	  compared	  to	  Haldimann’s	  method	  where	  he	  could	  record	  100	  nematodes	  at	  once.	  But	  the	  biggest	  difference	  lies	  in	  the	  fact	  that	  the	  motility	  assays	   in	   this	   study	   takes	   directly	   and	   precisely	   in	   account	   the	   quality	   and	  quantity	  of	  tracks,	  and	  not	  just	  the	  capacity	  of	  reaching	  or	  not	  a	  goal	  in	  a	  chosen	  time,	  without	  knowing	  if	  those	  who	  cannot	  reach	  the	  goal	  are	  injured,	  lost	  their	  capacity	  of	  sensing	   the	  bacterial	  circle	  used	  as	  bait,	  or	  are	   indeed	  paralyzed	  by	  the	  polyQ	  disease	  expression.	  	  Time	   constraints	   did	   not	   allow	   us	   to	   analyze	   further	  why	   Haldimann’s	   results	  were	   that	  hard	   to	  reproduce.	  We	  already	  mentioned	   that	   the	  method	  was	  very	  much	   operator	   dependent,	   but	   maybe	   other	   factors	   could	   have	   played	   a	   role.	  Even	   though	   the	   strains	   used	   in	   my	   study	   were	   same	   strains	   they	   may	   have	  mutated,	   reducing	   their	   sensitivity	   to	   polyQ	   disease	   expression,	   thus	   reducing	  the	  difference	  of	  motility	  between	  polyQ0	  wild	  type	  and	  polyQ35	  nematodes.	  To	  verify	   this	  hypothesis,	  newly	  genetically	  modified	  nematodes	   strains	   should	  be	  used	   with	   our	   method	   and	   see	   if	   we	   could	   get	   results	   closer	   to	   the	   one	   of	  Haldimann’s,	  without	  needing	  to	  struggle	  with	  the	  operator	  dependent	  factor.	  To	   reflect	   the	   reality	   as	   accurately	   as	   possible,	   graphs	   are	   presented	   with	  boxplots.	  The	  aim	  of	  the	  study	  being	  a	  screening	  of	  ten	  drugs,	  the	  most	  important	  aspect	  to	  observe	  is	  a	  tendency	  of	  improvement	  or	  of	  toxicity,	  to	  see	  if	  the	  drug	  have	  a	  potential	  of	  slowing	  down	  or	  preventing	  the	  polyQ	  disease	  development.	  Boxplots	  can	  achieve	  this	  visual	  goal	  without	  relying	  on	  results	  with	  complicated	  statistical	   evaluations.	   Even	   with	   big	   differences	   between	   maximum	   and	  minimum	  values,	  the	  boxplot	  presentation	  allows	  us	  to	  observe	  well	  tendencies	  of	  improvement	  or	  reduction	  of	  motility.	  Big	  differences	   in	  maximum	  and	  minimum	  values	  could	  be	  explained	  either	  by	  uncontrollable	   biological	   bias	   (such	   as	   weather	   or	   care	   of	   nematodes	   for	  example)	  or	  by	  the	  fact	  that	  maybe	  not	  all	  the	  nematodes	  that	  have	  received	  the	  treatment	   respond	   to	   it	   and	   those	   that	   do	   react	   to	   the	   treatment	   see	   their	  motility	   improved	  greatly,	  showing	  a	  great	  gap	  between	  the	  values	  and	  making	  taller	  the	  boxplot.	  This	  could	  especially	  be	  the	  case	  of	  piroxicam	  and	  anisindione	  in	  the	  first	  part	  of	  the	  experiment.	  Another	  way	  to	  greatly	  improve	  the	  data	  acquisition	  of	  nematode	  motility	  would	  be	  to	  find	  a	  way	  of	  taking	  pictures	  of	  good	  quality	  with	  an	  instrument	  that	  could	  take	  a	   single	  picture	  of	   the	  whole	  dish,	  making	   the	   record	  of	   tracks	  easier	   and	  also	  avoiding	  the	  tiny	  bias	  of	  timing	  as	  several	  pictures	  were	  taken	  one	  after	  the	  other	  for	  each	  dish.	  Next	   should	   be	   discussed	   the	   way	   piroxicam	   acts	   in	   the	   cell	   to	   improve	   the	  polyQ35	  nematodes’	  motility.	   It	   has	   already	  been	   shown	   that	   in	  human	  gastric	  cells	   NSAID’s	   could	   induce	   the	   expression	   of	   chaperone	   proteins	   such	   as	   an	  oxygen-­‐	  and	  a	  glucose-­‐related	  protein	  (Namba	  et	  al.,	  2010).	  NSAID’s	  also	  increase	  intracellular	   concentration	   of	   Ca2+(Tsutsumi	   et	   al.,	   2006),	   an	   essential	   step	   for	  the	   chaperone	   proteins	   upregulation,	   by	   blocking	   the	   Ca2+-­‐ATPase	   of	   the	  endoplasmic	   reticulum	   (ER)	   and	   inhibiting	   the	   intra-­‐ER	   Ca2+	   reuptake	  mechanism.	   This	   could	   explain	   the	   effect	   of	   piroxicam	   on	   polyQ35’s	   motility	  improvement.	   However	   it	   doesn’t	   explain	  why	   piroxicam	   is	   the	   only	   NSAID	   of	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this	  study	  that	  had	  such	  an	  effect	  on	  polyQ35	  nematodes.	  Not	  all	  NSAID’s	  share	  the	  same	  mechanism	  of	  action	  so	   it	  would	  be	  wrong	   to	  generalize	   the	  effect	  of	  piroxicam	  to	  every	  NSAID’s.	  Indeed	  it	  has	  been	  shown	  that	  aspirin,	  a	  NSAID	  cox-­‐inhibitor	  can	  enhance	  HSP70	  accumulation	  in	  plants	  (Snyman	  and	  Cronjé,	  2008),	  that	   don’t	   have	   the	   cyclooxygenases	   (COX)	   enzyme,	   present	   in	   humans.	  Piroxicam	   could	   easily	   have	   another	   unknown	  mechanism	   of	   action	   than	   COX	  inhibition	   that	   could	   explain	   the	   fact	   that	   it’s	   the	   only	  NSAID	  of	   the	   study	   that	  showed	  such	  an	  effect	  on	  polyQ	  disease	  expressing	  nematodes.	  Toxicity	   of	   piroxicam	   on	   wild	   type	   C.elegans	   has	   also	   been	   observed	   in	   the	  experiment	   (see	   figure	   13).	   It	   didn’t	   have	   a	   clear	   effect	   on	   size	   of	   treated	  
C.elegans	   and	   it	  was	  not	  verified	   if	   it	   changed	   the	   life	   span	  or	   the	   reproductive	  profile	   of	   wild	   type	   C.elegans.	   The	   mechanism	   of	   the	   toxicity	   couldn’t	   be	  explained	   without	   further	   experiments,	   but	   this	   should	   not	   make	   the	   reader	  think	  that	  piroxicam	  as	  a	  polyQ	  disease	  possible	  treatment	  isn’t	  worth	  studying	  more	   because	   of	   a	   particular	   property	   of	   the	   studied	   model	   resulted	   in	   this	  negative	   observation.	   Indeed	   piroxicam	   is	   already	   a	   well	   known	   widely	   used	  NSAID	   drug	   in	   many	   different	   diseases.	   Our	   data	   cannot	   tell	   us	   if	   piroxicam	  reduced	  wild	  type	  nematode	  by	  toxicity	  or	  by	  another	  mechanism,	   for	  example	  by	  changing	  their	  behavior	  and	  reducing	  their	  will	  to	  move.	  The	  concentration	  of	  1%	  DMSO	  showed	  toxicity	  on	  C.elegans	  during	   this	  study.	  DMSO	   is	   well	   known	   to	   rigidify	   membranes	   and	   as	   the	   membranes	   act	   as	   a	  sensor	  activating	  the	  heat	  shock	  response,	  we	  can	  easily	  imagine	  that	  the	  rigidity	  of	  the	  membranes	  that	  DMSO	  causes,	  renders	  the	  membranes	  physically	  unable	  to	  make	  the	  stress-­‐induced	  rearrangements	  needed	  to	  activate	  HSF-­‐1	  mentioned	  in	  figure	  5	  (Horváth	  et	  al.,	  2008).	  Toxicity	  on	  wild	  type	  Q0	  nematodes	  can	  either	  be	  explained	  by	  the	  fact	  that	   in	  the	  environmental	  conditions	  of	  the	  study	  even	  polyQ0	  nematodes	  need	  a	   little	  heat	  shock	  response	  (hypothetically	  blocked	  by	  the	  action	  of	  DMSO)	  to	  keep	  equilibrated	  proteostasis,	  either	  by	  a	  direct	  toxicity	  through	  unknown	  mechanism.	  Chloroform	   didn’t	   show	   such	   toxicity	   on	   wild	   type	   C.elegans	   and	   could	   dilute	  piroxicam	  better,	  enabling	  us	  to	  mix	  it	  with	  the	  NGM	  medium	  and	  proving	  itself	  better	   than	   DMSO	   in	   this	   situation.	   This	   can	   be	   useful	   information	   for	   further	  study	  on	  C.elegans.	  To	  complete	  this	  study	  many	  other	  things	  could	  have	  been	  done.	   If	   time	  would	  have	  permitted	  it,	  we	  could	  have	  measured	  induced	  RNA	  with	  microarrays	  and	  see	  if	  the	  expression	  of	  particular	  chaperone	  protein	  genes	  were	  overexpressed,	  we	  could	  also	  have	  made	  western	  blots	  to	  observe	  directly	  the	  augmentation	  in	  quantity	   of	   HSP’s,	   HSP70	   and	   HSP90	   for	   example	   and	   see	   if	   they	   were	  upregulated	   and	   finally	   compare	  RNA	  overexpression	   and	   augmented	   proteins	  production.	  	  	  	  
	  	   28	  
As	   a	   conclusion	  we	  would	   recommend	   further	   studies	  on	  piroxicam	  as	   a	  dose-­‐dependent	  elicitor	  of	  chaperone	  proteins,	  including	  on	  other	  models	  to	  verify	  its	  toxicity	  on	  non-­‐polyQ	  expressing	  genotype.	  Anisindione	  would	  also	  be	   another	  possible	  promising	  drug	  to	  test.	  The	  method	  used	  for	  this	  study	  is	  recommended	  for	   quick	   but	   not	   very	   sensitive	   screening	   with	   C.elegans’	   model.	   DMSO	   that	  rigidifies	  membranes	  wouldn’t	  be	  advised	  as	  a	  drug	  solvent	  on	  C.elegans	  for	   its	  previously	  discussed	   toxicity,	   and	   chloroform	  could	  be	   a	   substitute	  of	   choice	   if	  drugs	  dilution	  permits	  it.	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Appendix	  1	  
	  
Caenorhbaditis	  elegans’	  synchronisation	  protocol	  :	  
	  Egg	  preparation	  :	  removing	  bacterial	  or	  yeast	  contaminants	  from	  C.elegans	  stock	  plates.	  	  
Equipment	  and	  reagents	  -­‐ 5M	  NaOH	  -­‐ Household	  bleach	  (5%	  solution	  of	  sodium	  hypochloride)	  -­‐ Sterile	  15ml	  capped	  conical	  centrifuge	  tube	  -­‐ Shaker	  or	  vortex	  mixer	  -­‐ Table-­‐top	  centrifuge	  -­‐ Sterile	  Pasteur	  pipettes	  -­‐ Two	  clean	  NGM	  plates,	  each	  seeded	  with	  an	  E.coli	  OP50	  lawn	  
	  
Method	  
1. Use	   contaminated	   C.elegans	   stock	   plates	   that	   have	   many	   gravid	  hermaphroditesa.	   Wash	   the	   plates	   with	   sterile	   H2O.	   Pipette	   the	   H2O	  across	   the	   plates	   several	   times	   to	   the	   loosen	  worms	   and	   eggs	   that	   are	  stock	  in	  the	  bacteria	  lawn.	  
2. Collect	   the	   liquid	   and	  worms	   in	   a	   sterile	   15	  ml	   conical	   centrifuge	   tube	  with	  a	  cap.	  Add	  H2O	  to	  a	  total	  volume	  of	  3.5	  ml.	  
3. Mix	  0.5	  ml	  5M	  NaOH	  with	  1	  ml	  bleach.	  Make	   this	   solution	   fresh	  before	  us	  !	  Add	  to	  the	  centrifuge	  tube	  containing	  the	  worms.	  
4. Shake	   well	   or	   vortex	   the	   tube	   for	   a	   few	   seconds.	   Repeat	   shaking/	  vortexing	  every	  2	  minutes	  for	  a	  total	  of	  8	  minutes.	  
5. Centrifuge	   in	   a	   tabletop	   centrifuge	   for	   30	   sec	   at	   1300	   g	   to	   pellet	   the	  released	  eggs.	  
6. Aspirate	  to	  0.1	  ml.	  
7. Add	  sterile	  H2O	  to	  5	  ml.	  Shake	  well	  or	  vortex	  for	  a	  few	  seconds.	  
8. Repeat	  steps	  5	  and	  6	  two	  times,	  the	  second	  time	  centrifuging	  for	  1	  min.	  
9. Use	  a	  sterile	  Pasteur	  pipette	  to	  transfer	  the	  eggs	  in	  the	  remaining	  0.1	  ml	  of	   liquid	   to	   the	   edge	   of	   a	   clean	  NGM	   plate	   seeded	  with	   an	  E.Coli	  OP50	  lawn.	  
10. The	  next	  day	  the	  eggs	  will	  have	  hatched	  and	  the	  larvae	  will	  have	  crawled	  into	   the	  E.Coli	  OP50	   lawn.	   Transfer	   the	   hatched	   larvae	   to	   a	   clean	  NGM	  plate	  seeded	  with	  a	  lawn.	  	  a	  It	  is	  embryos	  inside	  eggshells	  that	  will	  survive	  this	  procedure.	  
